Specific, metabolism-driven transporters in excretory epithelia and barrier tissues play a important role in determining xenobiotic uptake, distribution and excretion. Along with xenobiotic metabolizing enzymes, these transporters are our first defense against chemical toxins. We use comparative models (renal proximal tubules from lower vertebrates, mammalian cells in culture derived from kidney and choroid plexus and intact mammalian and fish choroid plexus and brain microvessels) in combination with confocal microscopy, intracellular microinjection and isolated membrane vesicle techniques to define the cellular mechanisms that drive xenobiotic transport. Although work continues on the cellular and molecular biology of renal transport mechanisms, recent emphasis has been on development of imaging-based techniques to define mechanisms responsible for transport of foreign chemicals out of the central nervous system (CNS). First, we have used isolated brain capillaries and confocal microscopy to identify the transporters responsible for poor penetration of therapeutic drugs into the brain. For example, the somatostatin analogue, octreotide, is also handled by the ATP-driven export pumps, p-glycoprotein and Mrp2, but the chemotherapeutic, taxol, is only handled by p-glycoprotein. We then used this knowledge and an in vitro/in vivo approach to demonstrate that inhibition of p-glycoprotein both increased taxol entry into mouse brain and provided a remarkable therapeutic advantage in the treatment of an implanted human glioblastoma. Second, using a combination of radiotracer, GFP and confocal imaging techniques as well as knockout technology we localized Oat1, Oat3 and Oct2 to the apical (CSF-side) membrane of the epithelium, which is the correct location for these transporters to mediate uptake from the CSF of organic anions and organic cations, respectively. For the anionic herbicide, 2,4-D and the fluorescent organic anion, fluorescein, we found that uptake by intact rat plexus and isolated bovine apical plasma membrane vesicles was indirectly coupled to Na as one would expect for transport mediated by an Oat family transporter. With imaging we could visualize the entire process of transepithelial organic anion transport and examine for the first time the step from cell to blood, which proved to be both carrier-mediated and (unlike proximal tubule) potential sensitive. Since uptake of several organic anions from the apical side of the tissue appeared to be energetically coupled to Na and since Oat3 was not believed to be an anion exchanger, we were surprised to discover that FL uptake in choroid plexus from an Oat3 kockout mouse is reduced by more than 50%. We are currently investigating the mechanism by which transport on Oat3 is coupled to Na.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES080048-12
Application #
6673240
Study Section
(LPC)
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
Indirect Cost
Name
U.S. National Inst of Environ Hlth Scis
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Durk, Matthew R; Chan, Gary N Y; Campos, Christopher R et al. (2012) 1?,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells. J Neurochem 123:944-53
Hawkins, Brian T; Sykes, Destiny B; Miller, David S (2010) Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. J Neurosci 30:1417-25
Hartz, Anika M S; Miller, David S; Bauer, Björn (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 77:715-23
Zibell, Guido; Unkruer, Bernadette; Pekcec, Anton et al. (2009) Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology 56:849-55
Hartz, Anika M S; Bauer, Bjorn; Block, Michelle L et al. (2008) Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J 22:2723-33
Miller, David S; Bauer, Bjorn; Hartz, Anika M S (2008) Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 60:196-209
Bauer, Bjorn; Hartz, Anika M S; Lucking, Jonathan R et al. (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab 28:1222-34
Bauer, Bjorn; Hartz, Anika M S; Pekcec, Anton et al. (2008) Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol 73:1444-53
Festuccia, William T; Oztezcan, Serdar; Laplante, Mathieu et al. (2008) Peroxisome proliferator-activated receptor-gamma-mediated positive energy balance in the rat is associated with reduced sympathetic drive to adipose tissues and thyroid status. Endocrinology 149:2121-30
Bow, Daniel A J; Perry, Jennifer L; Miller, David S et al. (2008) Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes. Drug Metab Dispos 36:198-202

Showing the most recent 10 out of 53 publications